Toll Free: 1-888-928-9744
Published: Aug, 2017 | Pages:
103 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
This report studies the global Bioengineered Proteins Drugs market, analyzes and researches the Bioengineered Proteins Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like • Eli Lilly • F. Hoffmann-La Roche • Sanofi • Pfizer • GlaxoSmithKline • Novartis • Allergan • AbbVie • Agilent Technologies • Panacea Biotec • Wockhardt Market segment by Regions/Countries, this report covers • United States • EU • Japan • China • India • Southeast Asia Market segment by Type, Bioengineered Proteins Drugs can be split into • Cytokines and Chemokines • Monoclonal Antibodies • Therapeutic Enzymes • Peptide Hormones • Peptide Antibiotics • Vaccines • Other Market segment by Application, Bioengineered Proteins Drugs can be split into • Diabetes and Hormonal Disorders • Genetic and Fertility Disorders • Cancers • Organ Transplants • Others If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents Global Bioengineered Proteins Drugs Market Size, Status and Forecast 2022 1 Industry Overview of Bioengineered Proteins Drugs 1.1 Bioengineered Proteins Drugs Market Overview 1.1.1 Bioengineered Proteins Drugs Product Scope 1.1.2 Market Status and Outlook 1.2 Global Bioengineered Proteins Drugs Market Size and Analysis by Regions 1.2.1 United States 1.2.2 EU 1.2.3 Japan 1.2.4 China 1.2.5 India 1.2.6 Southeast Asia 1.3 Bioengineered Proteins Drugs Market by Type 1.3.1 Cytokines and Chemokines 1.3.2 Monoclonal Antibodies 1.3.3 Therapeutic Enzymes 1.3.4 Peptide Hormones 1.3.5 Peptide Antibiotics 1.3.6 Vaccines 1.3.7 Other 1.4 Bioengineered Proteins Drugs Market by End Users/Application 1.4.1 Diabetes and Hormonal Disorders 1.4.2 Genetic and Fertility Disorders 1.4.3 Cancers 1.4.4 Organ Transplants 1.4.5 Others 2 Global Bioengineered Proteins Drugs Competition Analysis by Players 2.1 Bioengineered Proteins Drugs Market Size (Value) by Players (2016 and 2017) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 Eli Lilly 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Bioengineered Proteins Drugs Revenue (Value) (2012-2017) 3.1.5 Recent Developments 3.2 F. Hoffmann-La Roche 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Bioengineered Proteins Drugs Revenue (Value) (2012-2017) 3.2.5 Recent Developments 3.3 Sanofi 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Bioengineered Proteins Drugs Revenue (Value) (2012-2017) 3.3.5 Recent Developments 3.4 Pfizer 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Bioengineered Proteins Drugs Revenue (Value) (2012-2017) 3.4.5 Recent Developments 3.5 GlaxoSmithKline 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Bioengineered Proteins Drugs Revenue (Value) (2012-2017) 3.5.5 Recent Developments 3.6 Novartis 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Bioengineered Proteins Drugs Revenue (Value) (2012-2017) 3.6.5 Recent Developments 3.7 Allergan 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Bioengineered Proteins Drugs Revenue (Value) (2012-2017) 3.7.5 Recent Developments 3.8 AbbVie 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Bioengineered Proteins Drugs Revenue (Value) (2012-2017) 3.8.5 Recent Developments 3.9 Agilent Technologies 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Bioengineered Proteins Drugs Revenue (Value) (2012-2017) 3.9.5 Recent Developments 3.10 Panacea Biotec 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Bioengineered Proteins Drugs Revenue (Value) (2012-2017) 3.10.5 Recent Developments 3.11 Wockhardt 4 Global Bioengineered Proteins Drugs Market Size by Type and Application (2012-2017) 4.1 Global Bioengineered Proteins Drugs Market Size by Type (2012-2017) 4.2 Global Bioengineered Proteins Drugs Market Size by Application (2012-2017) 4.3 Potential Application of Bioengineered Proteins Drugs in Future 4.4 Top Consumer/End Users of Bioengineered Proteins Drugs 5 United States Bioengineered Proteins Drugs Development Status and Outlook 5.1 United States Bioengineered Proteins Drugs Market Size (2012-2017) 5.2 United States Bioengineered Proteins Drugs Market Size and Market Share by Players (2016 and 2017) 6 EU Bioengineered Proteins Drugs Development Status and Outlook 6.1 EU Bioengineered Proteins Drugs Market Size (2012-2017) 6.2 EU Bioengineered Proteins Drugs Market Size and Market Share by Players (2016 and 2017) 7 Japan Bioengineered Proteins Drugs Development Status and Outlook 7.1 Japan Bioengineered Proteins Drugs Market Size (2012-2017) 7.2 Japan Bioengineered Proteins Drugs Market Size and Market Share by Players (2016 and 2017) 8 China Bioengineered Proteins Drugs Development Status and Outlook 8.1 China Bioengineered Proteins Drugs Market Size (2012-2017) 8.2 China Bioengineered Proteins Drugs Market Size and Market Share by Players (2016 and 2017) 9 India Bioengineered Proteins Drugs Development Status and Outlook 9.1 India Bioengineered Proteins Drugs Market Size (2012-2017) 9.2 India Bioengineered Proteins Drugs Market Size and Market Share by Players (2016 and 2017) 10 Southeast Asia Bioengineered Proteins Drugs Development Status and Outlook 10.1 Southeast Asia Bioengineered Proteins Drugs Market Size (2012-2017) 10.2 Southeast Asia Bioengineered Proteins Drugs Market Size and Market Share by Players (2016 and 2017) 11 Market Forecast by Regions, Type and Application (2017-2022) 11.1 Global Bioengineered Proteins Drugs Market Size (Value) by Regions (2017-2022) 11.1.1 United States Bioengineered Proteins Drugs Revenue and Growth Rate (2017-2022) 11.1.2 EU Bioengineered Proteins Drugs Revenue and Growth Rate (2017-2022) 11.1.3 Japan Bioengineered Proteins Drugs Revenue and Growth Rate (2017-2022) 11.1.4 China Bioengineered Proteins Drugs Revenue and Growth Rate (2017-2022) 11.1.5 India Bioengineered Proteins Drugs Revenue and Growth Rate (2017-2022) 11.1.6 Southeast Asia Bioengineered Proteins Drugs Revenue and Growth Rate (2017-2022) 11.2 Global Bioengineered Proteins Drugs Market Size (Value) by Type (2017-2022) 11.3 Global Bioengineered Proteins Drugs Market Size by Application (2017-2022) 12 Bioengineered Proteins Drugs Market Dynamics 12.1 Bioengineered Proteins Drugs Market Opportunities 12.2 Bioengineered Proteins Drugs Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 Bioengineered Proteins Drugs Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 Bioengineered Proteins Drugs Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source
List of Tables and Figures Figure Bioengineered Proteins Drugs Product Scope Figure Global Bioengineered Proteins Drugs Market Size (Million USD) (2012-2017) Table Global Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Global Bioengineered Proteins Drugs Market Share by Regions in 2016 Figure United States Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure EU Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Japan Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure China Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure India Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Southeast Asia Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Global Bioengineered Proteins Drugs Market Share by Type in 2016 Figure Cytokines and Chemokines Market Size (Million USD) and Growth Rate (2012-2017) Figure Monoclonal Antibodies Market Size (Million USD) and Growth Rate (2012-2017) Figure Therapeutic Enzymes Market Size (Million USD) and Growth Rate (2012-2017) Figure Peptide Hormones Market Size (Million USD) and Growth Rate (2012-2017) Figure Peptide Antibiotics Market Size (Million USD) and Growth Rate (2012-2017) Figure Vaccines Market Size (Million USD) and Growth Rate (2012-2017) Figure Other Market Size (Million USD) and Growth Rate (2012-2017) Figure Global Bioengineered Proteins Drugs Market Share by Application in 2016 Table Key Downstream Customer in Diabetes and Hormonal Disorders Figure Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate in Diabetes and Hormonal Disorders (2012-2017) Table Key Downstream Customer in Genetic and Fertility Disorders Figure Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate in Genetic and Fertility Disorders (2012-2017) Table Key Downstream Customer in Cancers Figure Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate in Cancers (2012-2017) Table Key Downstream Customer in Organ Transplants Figure Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate in Organ Transplants (2012-2017) Table Key Downstream Customer in Others Figure Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate in Others (2012-2017) Table Bioengineered Proteins Drugs Market Size (Million USD) by Players (2016 and 2017) Figure Bioengineered Proteins Drugs Market Size Share by Players in 2016 Figure Bioengineered Proteins Drugs Market Size Share by Players in 2017 Table Eli Lilly Basic Information List Table Bioengineered Proteins Drugs Business Revenue (Million USD) of Eli Lilly (2012-2017) Figure Eli Lilly Bioengineered Proteins Drugs Business Revenue Market Share in 2016 Table F. Hoffmann-La Roche Basic Information List Table Bioengineered Proteins Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017) Figure F. Hoffmann-La Roche Bioengineered Proteins Drugs Business Revenue Market Share in 2016 Table Sanofi Basic Information List Table Bioengineered Proteins Drugs Business Revenue (Million USD) of Sanofi (2012-2017) Figure Sanofi Bioengineered Proteins Drugs Business Revenue Market Share in 2016 Table Pfizer Basic Information List Table Bioengineered Proteins Drugs Business Revenue (Million USD) of Pfizer (2012-2017) Figure Pfizer Bioengineered Proteins Drugs Business Revenue Market Share in 2016 Table GlaxoSmithKline Basic Information List Table Bioengineered Proteins Drugs Business Revenue (Million USD) of GlaxoSmithKline (2012-2017) Figure GlaxoSmithKline Bioengineered Proteins Drugs Business Revenue Market Share in 2016 Table Novartis Basic Information List Table Bioengineered Proteins Drugs Business Revenue (Million USD) of Novartis (2012-2017) Figure Novartis Bioengineered Proteins Drugs Business Revenue Market Share in 2016 Table Allergan Basic Information List Table Bioengineered Proteins Drugs Business Revenue (Million USD) of Allergan (2012-2017) Figure Allergan Bioengineered Proteins Drugs Business Revenue Market Share in 2016 Table AbbVie Basic Information List Table Bioengineered Proteins Drugs Business Revenue (Million USD) of AbbVie (2012-2017) Figure AbbVie Bioengineered Proteins Drugs Business Revenue Market Share in 2016 Table Agilent Technologies Basic Information List Table Bioengineered Proteins Drugs Business Revenue (Million USD) of Agilent Technologies (2012-2017) Figure Agilent Technologies Bioengineered Proteins Drugs Business Revenue Market Share in 2016 Table Panacea Biotec Basic Information List Table Bioengineered Proteins Drugs Business Revenue (Million USD) of Panacea Biotec (2012-2017) Figure Panacea Biotec Bioengineered Proteins Drugs Business Revenue Market Share in 2016 Table Wockhardt Basic Information List Table Bioengineered Proteins Drugs Business Revenue (Million USD) of Wockhardt (2012-2017) Figure Wockhardt Bioengineered Proteins Drugs Business Revenue Market Share in 2016 Table Global Bioengineered Proteins Drugs Market Size (Million USD) by Type (2012-2017) Figure Global Bioengineered Proteins Drugs Market Size Share by Type in 2012 Figure Global Bioengineered Proteins Drugs Market Size Share by Type in 2013 Figure Global Bioengineered Proteins Drugs Market Size Share by Type in 2014 Figure Global Bioengineered Proteins Drugs Market Size Share by Type in 2015 Figure Global Bioengineered Proteins Drugs Market Size Share by Type in 2016 Figure Global Bioengineered Proteins Drugs Market Size Share by Type in 2017 Table Global Bioengineered Proteins Drugs Market Size (Million USD) by Application (2012-2017) Figure Global Bioengineered Proteins Drugs Market Size (Million USD) by Application in 2012 Figure Global Bioengineered Proteins Drugs Market Size (Million USD) by Application in 2013 Figure Global Bioengineered Proteins Drugs Market Size (Million USD) by Application in 2014 Figure Global Bioengineered Proteins Drugs Market Size (Million USD) by Application in 2015 Figure Global Bioengineered Proteins Drugs Market Size (Million USD) by Application in 2016 Figure Global Bioengineered Proteins Drugs Market Size (Million USD) by Application in 2017 Table Top Consumer/End Users of Bioengineered Proteins Drugs Figure United States Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table United States Bioengineered Proteins Drugs Market Size (Million USD) by Players (2012-2017) Figure United States Bioengineered Proteins Drugs Market Size Share by Players in 2016 Figure United States Bioengineered Proteins Drugs Market Size Share by Players in 2017 Figure EU Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table EU Bioengineered Proteins Drugs Market Size (Million USD) by Players (2012-2017) Figure EU Bioengineered Proteins Drugs Market Size Share by Players in 2016 Figure EU Bioengineered Proteins Drugs Market Size Share by Players in 2017 Figure Japan Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table Japan Bioengineered Proteins Drugs Market Size (Million USD) by Players (2012-2017) Figure Japan Bioengineered Proteins Drugs Market Size Share by Players in 2016 Figure Japan Bioengineered Proteins Drugs Market Size Share by Players in 2017 Figure China Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table China Bioengineered Proteins Drugs Market Size (Million USD) by Players (2012-2017) Figure China Bioengineered Proteins Drugs Market Size Share by Players in 2016 Figure China Bioengineered Proteins Drugs Market Size Share by Players in 2017 Figure India Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table India Bioengineered Proteins Drugs Market Size (Million USD) by Players (2012-2017) Figure India Bioengineered Proteins Drugs Market Size Share by Players in 2016 Figure India Bioengineered Proteins Drugs Market Size Share by Players in 2017 Figure Southeast Asia Bioengineered Proteins Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table Southeast Asia Bioengineered Proteins Drugs Market Size (Million USD) by Players (2012-2017) Figure Southeast Asia Bioengineered Proteins Drugs Market Size Share by Players in 2016 Figure Southeast Asia Bioengineered Proteins Drugs Market Size Share by Players in 2017 Figure Global Bioengineered Proteins Drugs Market Size (Million USD) by Regions (2017-2022) Table Global Bioengineered Proteins Drugs Market Size (Million USD) by Regions (2017-2022) Figure Global Bioengineered Proteins Drugs Market Size Share by Regions in 2017 Figure Global Bioengineered Proteins Drugs Market Size Share by Regions in 2022 Figure United States Bioengineered Proteins Drugs Revenue (Million USD) and Growth Rate (2017-2022) Figure EU Bioengineered Proteins Drugs Revenue (Million USD) and Growth Rate (2017-2022) Figure Japan Bioengineered Proteins Drugs Revenue (Million USD) and Growth Rate (2017-2022) Figure China Bioengineered Proteins Drugs Revenue (Million USD) and Growth Rate (2017-2022) Figure India Bioengineered Proteins Drugs Revenue (Million USD) and Growth Rate (2017-2022) Figure Southeast Asia Bioengineered Proteins Drugs Revenue (Million USD) and Growth Rate (2017-2022) Table Global Bioengineered Proteins Drugs Market Size (Million USD) by Type (2017-2022) Figure Global Bioengineered Proteins Drugs Market Size Share by Type in 2017 Figure Global Bioengineered Proteins Drugs Market Size Share by Type in 2022 Table Global Bioengineered Proteins Drugs Market Size (Million USD) by Application (2017-2022) Figure Global Bioengineered Proteins Drugs Market Size (Million USD) by Application in 2017 Figure Global Bioengineered Proteins Drugs Market Size (Million USD) by Application in 2022
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.